$4,011.41 travel Payment -- Takeda Pharmaceuticals to Dr. Benjamin Cook
Hematologist Benjamin Cook Receives $4,011.41 in Travel Payments from Takeda Pharmaceuticals
This page provides a detailed analysis of a $4,011.41 travel payment from Takeda Pharmaceuticals to Dr. Benjamin Cook. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $4,011.41 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Takeda Pharmaceuticals |
| Physician | Dr. Benjamin Cook |
| NPI Number | 1885234788 |
| Physician Specialty | Hematology |
| Location | Lowell, MA |
| Date of Payment | 2024-06-20 |
| Related Drug/Device | Mounjaro |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Takeda Pharmaceuticals made a $4.0K travel payment to Benjamin Cook, a Hematology specialist in Lowell, MA. The payment was associated with Mounjaro. Benjamin Cook received $4,011.41 from Takeda Pharmaceuticals for travel and lodging related to Mounjaro. The payment occurred on June 20, 2024, and was for services in Lowell, MA. This payment falls under the 'travel' category, indicating expenses covered for professional development or educational activities.
Patient Guidance: What This Payment Means for You
If you are a patient of Dr. Cook, this payment relates to his professional activities and does not directly impact your personal medical care. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
For a Hematologist, travel and lodging payments can be common for attending medical conferences or educational events related to their specialty, but the specific drug mentioned (Mounjaro) is typically used for diabetes, which is outside the primary scope of Hematology, warranting further context.
Regulatory Context: Sunshine Act Requirements
Payments to physicians for travel and lodging must be reported under the Open Payments program to ensure transparency in the relationships between healthcare providers and the pharmaceutical industry.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- takeda-pharmaceuticals
- hematology
- mounjaro
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $4.0K payment for?
This was a travel payment of $4.0K from Takeda Pharmaceuticals to Benjamin Cook, categorized as "Travel and Lodging". It was associated with Mounjaro. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Benjamin Cook accept pharmaceutical money?
Yes, Benjamin Cook received this $4.0K payment from Takeda Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Benjamin Cook's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $4.0K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Hematology?
To compare this payment against Hematology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Hematology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Benjamin Cook's relationship with Takeda Pharmaceuticals?
The payment amount is substantial for travel and lodging, suggesting a multi-day event or significant travel distance. This $4.0K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Hematology?
The specific drug mentioned, Mounjaro, is often associated with diabetes treatment, which may or may not align with a Hematology specialty.
What should patients do after learning about this payment?
If you are a patient of Dr. Cook, this payment relates to his professional activities and does not directly impact your personal medical care.
What else should I know about this travel payment?
The payment was made by Takeda Pharmaceuticals, a company known for a range of therapeutic areas.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.